Haemato-oncology specialists in Singapore

Diong Colin Phipps

Blood · Singapore

Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore. He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation. Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH). He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle. Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments. Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School. He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.

Diong Colin Phipps

Blood · Singapore

Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore. He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation. Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH). He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle. Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments. Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School. He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.

Diong Colin Phipps

Blood · Singapore

Dr Colin Phipps is a haematologist practising at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore. He specialises in lymphoma and blood cancers, and haematopoietic stem cell transplantation. Dr Phipps received his medical degree from the National University of Ireland in 2002 and subsequently completed internal medicine residency and specialist training in haematology at Singapore General Hospital (SGH). He was awarded the HMDP fellowship to pursue subspecialty training in lymphoma and bone marrow transplantation at the renowned Fred Hutchinson Cancer Research Centre in Seattle. Dr Phipps spent 10 years with the department of haematology at SGH. There, he was appointed as lymphoma director in 2012 and helped build the lymphoma programme, later becoming the lymphoma lead for the SingHealth-DUKE Blood Cancer Centre, which brought together lymphoma teams from SGH and National Cancer Centre Singapore. He has overseen the management of hundreds of patients with complex blood cancers, including resistant lymphomas and those undergoing transplantation. He also headed numerous pharmaceutical-sponsored and investigator-initiated clinical trials that have allowed patients access to many novel treatments. Dr Phipps is actively involved in undergraduate and postgraduate training of young doctors in Singapore. He has held roles including postgraduate mentor and senior lecturer with NUS Yong Loo Lin School of Medicine, as well as MBBS examiner and assistant adjunct professor with DUKE-NUS Medical School. He has authored more than 30 papers in peer-reviewed journals, including Transplantation, Critical Reviews in Oncology-Haematology, and Bone Marrow Transplantation. His expertise in the field of lymphoma and bone marrow transplantation has led him to serve as advisor to numerous regional and international expert panels and education programmes.

Lee Yuh Shan

Blood · Singapore

Dr Lee Yuh Shan is a haematologist at Gleneagles Hospital and Mount Elizabeth Novena Hospital, Singapore. He specialises in malignant haematology such as lymphoma, leukaemia, myeloma and haematopoietic stem cells transplant. He developed his specialty in lymphoma at the National Institutes of Health (NIH) in Maryland, United States, where he had first-hand experience in seeing patients under clinical trial with new oral therapy in the treatment of chronic lymphocytic leukemia (CLL) and aggressive lymphoma. He contributed to the development and incorporation of new agents in the treatment of lymphoma, as well as the development of investigator-initiated trials for aggressive lymphoma in the department of haematology at the Singapore General Hospital (SGH). Dr Lee worked for 10 years at SGH. He was the director of the lymphoma service in their department of haematology from 2017, and was the lymphoma lead at the SingHealth Duke Blood Cancer Centre (SDBCC) from 2018. He is active in collaborative works locally under the SDBCC and Singapore Lymphoma Working Group, as well as regionally for CLL. In addition, he is involved in many pharmaceutical sponsored trials and investigator-initiated trials, most of which focus on new agents in lymphoma and myeloma. Dr Lee is active in undergraduate medical training. He is a senior clinical tutor for the Yong Loo Lin School of Medicine at NUS, and is an adjunct associate professor at the Duke-NUS Medical School. He is also a faculty member of the senior residency programme in haematology at SGH. He is an active speaker at regional haematology symposiums especially in CLL/lymphoma. He also contributes to lymphoma support group and Singapore World Lymphoma Day. He has published in many peer-reviewed journals and is a reviewer for peer-reviewed journals. He is also a member of SingHealth Institutional Review Board (IRB) and sat on several pharmaceutical advisory boards.

Lee Yuh Shan

Blood · Singapore

Dr Lee Yuh Shan is a haematologist at Gleneagles Hospital and Mount Elizabeth Novena Hospital, Singapore. He specialises in malignant haematology such as lymphoma, leukaemia, myeloma and haematopoietic stem cells transplant. He developed his specialty in lymphoma at the National Institutes of Health (NIH) in Maryland, United States, where he had first-hand experience in seeing patients under clinical trial with new oral therapy in the treatment of chronic lymphocytic leukemia (CLL) and aggressive lymphoma. He contributed to the development and incorporation of new agents in the treatment of lymphoma, as well as the development of investigator-initiated trials for aggressive lymphoma in the department of haematology at the Singapore General Hospital (SGH). Dr Lee worked for 10 years at SGH. He was the director of the lymphoma service in their department of haematology from 2017, and was the lymphoma lead at the SingHealth Duke Blood Cancer Centre (SDBCC) from 2018. He is active in collaborative works locally under the SDBCC and Singapore Lymphoma Working Group, as well as regionally for CLL. In addition, he is involved in many pharmaceutical sponsored trials and investigator-initiated trials, most of which focus on new agents in lymphoma and myeloma. Dr Lee is active in undergraduate medical training. He is a senior clinical tutor for the Yong Loo Lin School of Medicine at NUS, and is an adjunct associate professor at the Duke-NUS Medical School. He is also a faculty member of the senior residency programme in haematology at SGH. He is an active speaker at regional haematology symposiums especially in CLL/lymphoma. He also contributes to lymphoma support group and Singapore World Lymphoma Day. He has published in many peer-reviewed journals and is a reviewer for peer-reviewed journals. He is also a member of SingHealth Institutional Review Board (IRB) and sat on several pharmaceutical advisory boards.

Lee Yuh Shan

Blood · Singapore

Dr Lee Yuh Shan is a haematologist at Gleneagles Hospital and Mount Elizabeth Novena Hospital, Singapore. He specialises in malignant haematology such as lymphoma, leukaemia, myeloma and haematopoietic stem cells transplant. He developed his specialty in lymphoma at the National Institutes of Health (NIH) in Maryland, United States, where he had first-hand experience in seeing patients under clinical trial with new oral therapy in the treatment of chronic lymphocytic leukemia (CLL) and aggressive lymphoma. He contributed to the development and incorporation of new agents in the treatment of lymphoma, as well as the development of investigator-initiated trials for aggressive lymphoma in the department of haematology at the Singapore General Hospital (SGH). Dr Lee worked for 10 years at SGH. He was the director of the lymphoma service in their department of haematology from 2017, and was the lymphoma lead at the SingHealth Duke Blood Cancer Centre (SDBCC) from 2018. He is active in collaborative works locally under the SDBCC and Singapore Lymphoma Working Group, as well as regionally for CLL. In addition, he is involved in many pharmaceutical sponsored trials and investigator-initiated trials, most of which focus on new agents in lymphoma and myeloma. Dr Lee is active in undergraduate medical training. He is a senior clinical tutor for the Yong Loo Lin School of Medicine at NUS, and is an adjunct associate professor at the Duke-NUS Medical School. He is also a faculty member of the senior residency programme in haematology at SGH. He is an active speaker at regional haematology symposiums especially in CLL/lymphoma. He also contributes to lymphoma support group and Singapore World Lymphoma Day. He has published in many peer-reviewed journals and is a reviewer for peer-reviewed journals. He is also a member of SingHealth Institutional Review Board (IRB) and sat on several pharmaceutical advisory boards.

Mya Hae Tha DawnMRCP

Blood · Singapore

Dr Dawn Mya is a haematologist at Mount Elizabeth Novena Hospital, Singapore. She has a special interest in haematological malignancies including acute leukaemia, lymphoma and multiple myeloma. She manages all general haematology conditions and the disorders of thrombosis and haemostasis, obstetric haematology, and chronic myeloid and lymphoid diseases. She was formerly a consultant haematologist at a private hospital. She also worked as a consultant in the department of haematology at Singapore General Hospital (SGH) where she is currently a visiting consultant overseeing the flow cytometry services for minimal residual diseases for haematological malignancies. Dr Mya graduated with a bachelor's degree from the University of Medicine, Yangon and subsequently obtained her MRCP from the UK in 2008. She completed her haematology training at SGH and was accredited as a specialist for haematology in 2013. She is a fellow of the Royal College of Pathologists, UK, in haematology. She received the Health Manpower Development Plan award and did her subspecialty training on the utility of flow cytometry in diagnosis and minimal residual disease assessment of haematological malignancies in the departments of haematology and flow cytometry services at the University of Salamanca, Spain. She has an accreditation for both clinical and laboratory haematology. She was an adjunct assistant professor at Duke-NUS Medical School and a senior clinical lecturer at Yong Loo Lin School of Medicine. Dr Mya received the SingHealth EPIC award in 2013 for leading the team which implemented a new workflow that reduces the time taken for blood products to reach patients. She also received the SingHealth Service Quality Partner Award, SingHealth Quality Service Award (Gold) and SingHealth Quality Service Award (Star).

Mya Hae Tha DawnMRCP

Blood · Singapore

Dr Dawn Mya is a haematologist at Mount Elizabeth Novena Hospital, Singapore. She has a special interest in haematological malignancies including acute leukaemia, lymphoma and multiple myeloma. She manages all general haematology conditions and the disorders of thrombosis and haemostasis, obstetric haematology, and chronic myeloid and lymphoid diseases. She was formerly a consultant haematologist at a private hospital. She also worked as a consultant in the department of haematology at Singapore General Hospital (SGH) where she is currently a visiting consultant overseeing the flow cytometry services for minimal residual diseases for haematological malignancies. Dr Mya graduated with a bachelor's degree from the University of Medicine, Yangon and subsequently obtained her MRCP from the UK in 2008. She completed her haematology training at SGH and was accredited as a specialist for haematology in 2013. She is a fellow of the Royal College of Pathologists, UK, in haematology. She received the Health Manpower Development Plan award and did her subspecialty training on the utility of flow cytometry in diagnosis and minimal residual disease assessment of haematological malignancies in the departments of haematology and flow cytometry services at the University of Salamanca, Spain. She has an accreditation for both clinical and laboratory haematology. She was an adjunct assistant professor at Duke-NUS Medical School and a senior clinical lecturer at Yong Loo Lin School of Medicine. Dr Mya received the SingHealth EPIC award in 2013 for leading the team which implemented a new workflow that reduces the time taken for blood products to reach patients. She also received the SingHealth Service Quality Partner Award, SingHealth Quality Service Award (Gold) and SingHealth Quality Service Award (Star).

Mya Hae Tha DawnMRCP

Blood · Singapore

Dr Dawn Mya is a haematologist at Mount Elizabeth Novena Hospital, Singapore. She has a special interest in haematological malignancies including acute leukaemia, lymphoma and multiple myeloma. She manages all general haematology conditions and the disorders of thrombosis and haemostasis, obstetric haematology, and chronic myeloid and lymphoid diseases. She was formerly a consultant haematologist at a private hospital. She also worked as a consultant in the department of haematology at Singapore General Hospital (SGH) where she is currently a visiting consultant overseeing the flow cytometry services for minimal residual diseases for haematological malignancies. Dr Mya graduated with a bachelor's degree from the University of Medicine, Yangon and subsequently obtained her MRCP from the UK in 2008. She completed her haematology training at SGH and was accredited as a specialist for haematology in 2013. She is a fellow of the Royal College of Pathologists, UK, in haematology. She received the Health Manpower Development Plan award and did her subspecialty training on the utility of flow cytometry in diagnosis and minimal residual disease assessment of haematological malignancies in the departments of haematology and flow cytometry services at the University of Salamanca, Spain. She has an accreditation for both clinical and laboratory haematology. She was an adjunct assistant professor at Duke-NUS Medical School and a senior clinical lecturer at Yong Loo Lin School of Medicine. Dr Mya received the SingHealth EPIC award in 2013 for leading the team which implemented a new workflow that reduces the time taken for blood products to reach patients. She also received the SingHealth Service Quality Partner Award, SingHealth Quality Service Award (Gold) and SingHealth Quality Service Award (Star).

Teo Cheng Peng Freddy

Blood · Singapore

Dr Teo Cheng Peng is a haematologist practising at Gleneagles Hospital and Mount Elizabeth Hospitals, Singapore. He was awarded the Public Service Commission Scholarship by the Singapore government to study medicine at the National University Hospital. His clinical interests are in haematology and oncology. He graduated in 1984 and completed the postgraduate examination in 1987. Under another scholarship, he received further specialised training in stem cell transplantation at the Royal Marsden Hospital, a leading cancer centre in the UK. Upon returning, Dr Teo started the Bone Marrow and Peripheral Blood Stem Cell Transplant programme at the National University Hospital. In 1995, he was then recruited to develop the Autologous Stem Cell Transplant programme for solid tumours in the department of medical oncology at the Singapore General Hospital. After successful implementation of the clinical programme, he continued his career and work in Gleneagles Hospital, with stem cells in the fields of haematology and medical oncology. Dr Teo continued to develop his interest in the field of stem cells and was one of the pioneers in starting an autologous stem cell bank in Singapore. Dr Teo is the chairman of Gleneagles Hospital's Blood Transfusion Committee. He is also a member of the Singapore Society of Haematology, Singapore Bone Marrow Donor Programme, Singapore Society of Oncology, Society of Transplantation (Singapore), International Society of Haematology and Graft Engineering , and the International Society of Haematology.

Teo Cheng Peng Freddy

Blood · Singapore

Dr Teo Cheng Peng is a haematologist practising at Gleneagles Hospital and Mount Elizabeth Hospitals, Singapore. He was awarded the Public Service Commission Scholarship by the Singapore government to study medicine at the National University Hospital. His clinical interests are in haematology and oncology. He graduated in 1984 and completed the postgraduate examination in 1987. Under another scholarship, he received further specialised training in stem cell transplantation at the Royal Marsden Hospital, a leading cancer centre in the UK. Upon returning, Dr Teo started the Bone Marrow and Peripheral Blood Stem Cell Transplant programme at the National University Hospital. In 1995, he was then recruited to develop the Autologous Stem Cell Transplant programme for solid tumours in the department of medical oncology at the Singapore General Hospital. After successful implementation of the clinical programme, he continued his career and work in Gleneagles Hospital, with stem cells in the fields of haematology and medical oncology. Dr Teo continued to develop his interest in the field of stem cells and was one of the pioneers in starting an autologous stem cell bank in Singapore. Dr Teo is the chairman of Gleneagles Hospital's Blood Transfusion Committee. He is also a member of the Singapore Society of Haematology, Singapore Bone Marrow Donor Programme, Singapore Society of Oncology, Society of Transplantation (Singapore), International Society of Haematology and Graft Engineering , and the International Society of Haematology.

Teo Cheng Peng Freddy

Blood · Singapore

Dr Teo Cheng Peng is a haematologist practising at Gleneagles Hospital and Mount Elizabeth Hospitals, Singapore. He was awarded the Public Service Commission Scholarship by the Singapore government to study medicine at the National University Hospital. His clinical interests are in haematology and oncology. He graduated in 1984 and completed the postgraduate examination in 1987. Under another scholarship, he received further specialised training in stem cell transplantation at the Royal Marsden Hospital, a leading cancer centre in the UK. Upon returning, Dr Teo started the Bone Marrow and Peripheral Blood Stem Cell Transplant programme at the National University Hospital. In 1995, he was then recruited to develop the Autologous Stem Cell Transplant programme for solid tumours in the department of medical oncology at the Singapore General Hospital. After successful implementation of the clinical programme, he continued his career and work in Gleneagles Hospital, with stem cells in the fields of haematology and medical oncology. Dr Teo continued to develop his interest in the field of stem cells and was one of the pioneers in starting an autologous stem cell bank in Singapore. Dr Teo is the chairman of Gleneagles Hospital's Blood Transfusion Committee. He is also a member of the Singapore Society of Haematology, Singapore Bone Marrow Donor Programme, Singapore Society of Oncology, Society of Transplantation (Singapore), International Society of Haematology and Graft Engineering , and the International Society of Haematology.